STOCK TITAN

Celestica Inc (CLS) director David Reeder granted 133 new D-RSUs

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Reeder David reported acquisition or exercise transactions in this Form 4 filing.

CELESTICA INC director David Reeder reported an equity compensation grant of 133 Director Restricted Share Units (D-RSUs) on August 11, 2026. Each D-RSU represents a contingent right to receive one common share or an equivalent cash value upon settlement, and the granted D-RSUs vest on May 20, 2027. Following this award, Reeder holds 700 D-RSUs directly.

Positive

  • None.

Negative

  • None.
Insider Reeder David
Role Director
Type Security Shares Price Value
Grant/Award Director Restricted Share Units F1, F2 133 $0.00 $0.00
Holdings After Transaction: Director Restricted Share Units — 700 shares (Direct)
Footnotes (2)
  1. F1. Each director restricted share unit ("D-RSU") represents a contingent right to receive one common share upon settlement, subject to the reporting person's deferral election, or, at the Issuer's election, an equivalent value in cash.
  2. F2. On August 11, 2026, the reporting person was granted 133 D-RSUs, which vest on May 20, 2027.
D-RSUs granted 133 units Director Restricted Share Units granted on August 11, 2026
D-RSU holdings after grant 700 units Total Director Restricted Share Units directly held after the transaction
Grant date August 11, 2026 Date the 133 D-RSUs were granted
Vesting date May 20, 2027 Date on which the 133 granted D-RSUs vest
Transaction price per unit $0.0000 Reported price per D-RSU for the equity award
Underlying common shares 133 shares Common shares underlying the 133 D-RSUs granted
Director Restricted Share Units financial
"Each director restricted share unit ("D-RSU") represents a contingent right"
contingent right financial
"represents a contingent right to receive one common share upon settlement"
vest financial
"the reporting person was granted 133 D-RSUs, which vest on May 20, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

What insider transaction did CELESTICA INC (CLS) report for David Reeder?

CELESTICA INC reported that director David Reeder received a grant of 133 Director Restricted Share Units on August 11, 2026 as equity compensation, increasing his directly held D-RSUs to 700.

How many Director Restricted Share Units did David Reeder receive at CELESTICA INC (CLS)?

David Reeder received 133 Director Restricted Share Units (D-RSUs). Each unit is a contingent right to receive one common share upon settlement, or, at the issuer’s election, an equivalent value in cash.

When do David Reeder’s new D-RSUs at CELESTICA INC (CLS) vest?

The 133 D-RSUs granted to David Reeder on August 11, 2026 vest on May 20, 2027. Vesting must occur before the units can be settled in common shares or cash.

What does each Director Restricted Share Unit represent for CELESTICA INC (CLS)?

Each D-RSU represents a contingent right to receive one common share of CELESTICA INC upon settlement, subject to any deferral election, or an equivalent cash value at the issuer’s election.

What are David Reeder’s D-RSU holdings at CELESTICA INC (CLS) after this grant?

After the August 11, 2026 grant, David Reeder directly holds 700 Director Restricted Share Units of CELESTICA INC, as reported in the Form 4 filing data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Reeder David

(Last)(First)(Middle)
5140 YONGE STREET
SUITE 1900

(Street)
TORONTOM2N 6L7

(City)(State)(Zip)

ONTARIO, CANADA

(Country)
2. Issuer Name and Ticker or Trading Symbol
CELESTICA INC [ CLS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Director Restricted Share Units(1)08/11/2026A133 (2) (2)Common Shares133$0700D
Explanation of Responses:
1. Each director restricted share unit ("D-RSU") represents a contingent right to receive one common share upon settlement, subject to the reporting person's deferral election, or, at the Issuer's election, an equivalent value in cash.
2. On August 11, 2026, the reporting person was granted 133 D-RSUs, which vest on May 20, 2027.
/s/ Samantha Graff, attorney-in-fact08/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)